In July 2021, the Indonesian Food and Drug Monitoring Agency (BPOM) finally granted the Emergency Use Authorization for Ivermectin as the therapeutic drug to cure the Covid-19. This was due to the country’s “worst-case scenario” epidemic at the time according to officials. Indonesia experienced a spike in COVID-19 infection and deaths in July and was struggling to slow the virus transmission due to its high population. Indonesia is ranked as the world’s fourth most populous country. ... After the government authorized the use of Ivermectin for COVID-19 patients, the number of cases significantly plummeted since July.